The average one-year price target for Hoth Therapeutics (NasdaqCM:HOTH) has been revised to $5.10 / share. This is an increase of 11.11% from the prior estimate of $4.59 dated January 11, 2026. The ...
InvestorsHub on MSN
Hoth Therapeutics shares slide after shift toward AI semiconductor strategy (HOTH)
Company plans rebrand and expansion into AI infrastructure Hoth Therapeutics Inc. (NASDAQ:HOTH) shares dropped 10.9% in ...
Hoth Therapeutics Inc. (NASDAQ:HOTH) on Tuesday announced combined findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT. HT-KIT is a precision antisense ...
NEW YORK, March 27, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced the entry into a definitive agreement for the immediate ...
Detailed price information for Hoth Therapeutics Inc (HOTH-Q) from The Globe and Mail including charting and trades.
An update from Hoth Therapeutics ( (HOTH)) is now available. On April 30, 2026, Hoth Therapeutics received notice from Nasdaq that it was no longer in compliance with the exchange’s $1.00 minimum bid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results